Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Operating Costs and Expenses
QFR103385USNO • Economic Data from Federal Reserve Economic Data (FRED)
Latest Value
140,199.00
Year-over-Year Change
14.84%
Date Range
10/1/2000 - 4/1/2025
Summary
Tracks operating costs and expenses for U.S. pharmaceutical and medicine corporations. Provides critical insight into sector-specific financial dynamics.
Analysis & Context
This economic indicator provides valuable insights into current market conditions and economic trends. The data is updated regularly by the Federal Reserve and represents one of the most reliable sources for economic analysis.
Understanding this metric helps economists, policymakers, and investors make informed decisions about economic conditions and future trends. The interactive chart above allows you to explore historical patterns and identify key trends over time.
About This Dataset
This financial metric measures comprehensive operating expenses in the pharmaceuticals and medicines industry. It helps understand cost structures and economic performance.
Methodology
Data collected through quarterly corporate financial reporting and expense documentation.
Historical Context
Used by investors, analysts, and healthcare policy researchers to assess industry financial health.
Key Facts
- Quarterly pharmaceutical industry expense tracking
- Comprehensive operating cost measurement
- Critical for industry financial analysis
FAQs
Q: What does this economic indicator measure?
A: Tracks all other operating costs and expenses for U.S. pharmaceutical and medicine corporations. Provides comprehensive financial insight.
Q: How frequently is this data updated?
A: Quarterly financial reports are typically updated every three months. Offers current industry expense snapshots.
Q: Why is this indicator important?
A: Helps understand cost structures, financial performance, and economic trends in the pharmaceutical sector.
Q: How can investors use this data?
A: Assess industry financial health, compare corporate performance, and make informed investment decisions.
Q: What are potential data limitations?
A: Represents aggregate data, may not capture individual company nuances precisely.
Related Trends
Quarterly Financial Report: U.S. Corporations: Motion Picture and Sound Recording Industries: Short-Term Debt, Original Maturity of 1 Year or Less: Loans from Banks
QFR301512USNO
Quarterly Financial Report: U.S. Corporations: Aerospace Products and Parts: Current Portion of Long-Term Debt, Due in 1 Year or Less: Other Long-Term Loans
QFRD313386USNO
Quarterly Financial Report: U.S. Corporations: Fabricated Metal Products: Cash and Demand Deposits in the U.S.
QFR201332USNO
Quarterly Financial Report: U.S. Corporations: Food and Beverage Stores: Retained Earnings
QFR322445USNO
Quarterly Financial Report: U.S. Corporations: Computer Systems Design and Related Services: Long-Term Debt, Due in More Than 1 Year: Other Long-Term Loans
QFRD319545USNO
Quarterly Financial Report: U.S. Corporations: All Information: Other Short-Term Financial Investments
QFRD210INFUSNO
Citation
U.S. Federal Reserve, Quarterly Financial Report: U.S. Corporations: Pharmaceuticals and Medicines: All Other Operating Costs and Expenses (QFR103385USNO), retrieved from FRED.